NASDAQ:EYESW Second Sight Medical Products (EYESW) Stock Price, News & Analysis → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free EYESW Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.01▼$0.0550-Day Range$0.00▼$0.2252-Week Range$0.18▼$1.02Volume75,101 shsAverage Volume4,500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesSocial MediaStock AnalysisHeadlinesSocial Media Get Second Sight Medical Products alerts: Email Address Ad Monument Traders AllianceMake this ONE trade on Tuesday at 2 p.m. EST!Every time the U.S. Government releases jobs, inflation, GDP and other Economic Reports… Use The JOLTS Loophole to target up to 253%... 327%... Even 383% Overnight Profits!Discover The Secret Loophole BEFORE Tuesday! About Second Sight Medical Products Stock (NASDAQ:EYESW)Read More Ad Monument Traders AllianceMake this ONE trade on Tuesday at 2 p.m. EST!Every time the U.S. Government releases jobs, inflation, GDP and other Economic Reports… Use The JOLTS Loophole to target up to 253%... 327%... Even 383% Overnight Profits!Discover The Secret Loophole BEFORE Tuesday! EYESW Stock News HeadlinesMay 16 at 10:06 AM | msn.comPeter Alexander's sister Rebecca started to lose her sight at 12. It was a sign of a rare diseaseMay 2, 2024 | markets.businessinsider.comEye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' AnalystMay 1, 2024 | msn.comVaping poses unexpected risks to eye health, study findsApril 30, 2024 | techcrunch.comneuroClues wants to put high speed eye tracking tech in the doctor’s officeApril 29, 2024 | msn.com10 Things You Should Be Doing Today to Protect Your Eye HealthApril 26, 2024 | detroitnews.comDr. Roach: Eye drops safe to use with AMD medicationApril 23, 2024 | msn.comCrystal Clear Vision: Expert Advice for Preserving Healthy Eyes as You AgeApril 18, 2024 | msn.com'You want it to look perfect because it’s someone’s eye': Ocularists are small group and it's even tougher to get into the industryApril 17, 2024 | theguardian.com‘Pregnancy is not a disease’: why do so many women die giving birth in one of Africa’s richest countries?April 17, 2024 | msn.comMy Miscarriage Was “Common” — For Black Women That Isn’t Comforting, It’s TerrifyingApril 12, 2024 | msn.comFinally, Planned Parenthood will offer sedation for IUD insertions and removalsApril 4, 2024 | msn.comPilot in fatal hot air balloon crash in Arizona had elevated levels of ketamine in his system, report findsApril 3, 2024 | ca.style.yahoo.comThe Good Doctor Cast Exits, Ranked — Which One Hit You the Hardest?April 2, 2024 | msn.comEyestem to initiate human trials for its therapy to treat eye disorderMarch 30, 2024 | msn.com30+ Social Behaviors That Are Only Acceptable in the U.S.March 29, 2024 | msn.comOregon toddler receives life-changing surgery to correct rare eye syndrome: ‘Sassier, more energetic’February 23, 2024 | au.finance.yahoo.comQ4 2023 Evolent Health Inc Earnings CallFebruary 22, 2024 | uk.finance.yahoo.comQ1 2024 Analog Devices Inc Earnings CallFebruary 6, 2024 | msn.comScary but Common Dog ProblemsFebruary 6, 2024 | finance.yahoo.comIridex Corporation Receives European Patent on MicroPulse TechnologyFebruary 5, 2024 | msn.comScientifically Speaking | Eyes are windows to the soul – and the rest of your organsDecember 8, 2023 | msn.comFDA recalls 27 eye products after 4 customers lose eyesightNovember 22, 2023 | msn.comSight Care Review - Eyes Supplement Scam Or Legit To Use? Ingredients, Reviews, And Studies (Critical Update)November 16, 2023 | msn.comSightcare Reviews - What Does Sight Care Official Website Say About Real Customer Results?November 1, 2023 | msn.comFDA Warning: 27 Eye Drop Products Could Cause Eye InfectionsSee More Headlines Receive EYESW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryN/A Current SymbolNASDAQ:EYESW CUSIPN/A CIK1266806 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key Competitors4D pharmaNASDAQ:LBPSWFidelity Select WirelessNASDAQ:FWRLXG Medical InnovationsNASDAQ:GMVDWJupiter WellnessNASDAQ:JUPWWGlobal X Education ETFNASDAQ:EDUTView All Competitors This page (NASDAQ:EYESW) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Second Sight Medical Products Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
